Literature DB >> 29273222

Photophysics of diphenyl-pyrazole compounds in solutions and α-synuclein aggregates.

Anne M Reiner1, Felix Schmidt2, Sergey Ryazanov3, Andrei Leonov4, Daniel Weckbecker5, Andreas A Deeg1, Christian Griesinger6, Armin Giese7, Wolfgang Zinth8.   

Abstract

BACKGROUND: Recently diphenyl-pyrazole (DPP) compounds and especially anle138b were found to reduce the aggregation of α-synuclein or Tau protein in vitro as well as in a mouse model of neurodegenerative diseases [1,2]. Direct interaction of the DPPs with the fibrillar structure was identified by fluorescence spectroscopy. Thereby a strong dependence of the fluorescence on the surroundings could be identified [3].
METHODS: Stationary and time-resolved emission experiments were performed on DPP compounds substituted by different halogens.
RESULTS: The compounds reveal a pronounced dependence of the fluorescence on the surrounding solvent. In non-polar solvents they show strong emission in the blue part of the spectrum while in polar and proton donating solvents, such as water or acetic acid a dual fluorescence can be observed where a red-shifted emission points to a charge transfer in the excited state with large dipole moment. Non-radiative processes including photochemical reactions are observed for DPP substituted with heavy halogens. Upon binding of anle138b and its derivatives to protein fibrils in aqueous buffer, strong enhancement of the fluorescence at short wavelengths is found.
CONCLUSION: The investigations of the DPPs in different surroundings lead to a detailed model of the fluorescence characteristics. We propose a model for the binding in fibrils of different proteins, where the DPP is located in a hydrophobic groove independent of the specific sequence of the amino acids. GENERAL SIGNIFICANCE: These investigations characterize the binding site of the DPP anle138b in protein aggregates and contribute to the understanding of the therapeutic mode of action of this compound.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Diphenyl-pyrazole; Fluorescence; Parkinson's disease; Protein aggregation; anle138b; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 29273222     DOI: 10.1016/j.bbagen.2017.12.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  3 in total

1.  [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.

Authors:  Laura Kuebler; Sabrina Buss; Andrei Leonov; Sergey Ryazanov; Felix Schmidt; Andreas Maurer; Daniel Weckbecker; Anne M Landau; Thea P Lillethorup; Daniel Bleher; Ran Sing Saw; Bernd J Pichler; Christian Griesinger; Armin Giese; Kristina Herfert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-28       Impact factor: 9.236

2.  Role of Tyr-39 for the Structural Features of α-Synuclein and for the Interaction with a Strong Modulator of Its Amyloid Assembly.

Authors:  Oscar Palomino-Hernandez; Fiamma A Buratti; Pamela S Sacco; Giulia Rossetti; Paolo Carloni; Claudio O Fernandez
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

3.  Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial.

Authors:  Johannes Levin; Nand Sing; Sue Melbourne; Amber Morgan; Carla Mariner; Maria Grazia Spillantini; Michal Wegrzynowicz; Jeffrey W Dalley; Simon Langer; Sergey Ryazanov; Andrei Leonov; Christian Griesinger; Felix Schmidt; Daniel Weckbecker; Kai Prager; Torsten Matthias; Armin Giese
Journal:  EBioMedicine       Date:  2022-04-29       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.